Any dose adjustments should be made under prescriber guidance based on overall tolerability and glycaemic control, not specifically for urinary symptoms
Patients starting compounded semaglutide, tirzepatide, or other GLP-1 options through PlexusDx receive provider guidance on individualized titration and skin care planning
Clinical teams need efficient workflows, clean interfaces, fast charting, and a consolidated view of patient progress
However, persistent nausea throughout the day, nausea that interferes with eating or daily activities, or nausea accompanied by frequent vomiting suggests the dose exceeds your current tolerance
Following their release into the blood stream, incretin peptides are rapidly inactivated by enzymatic cleavage
Nature 540 , 139143 (2016)